Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
At close: Sep 4, 2026 · 4:00 PM EDT

Incyte (INCY) Net Income (2010 - 2026)

Incyte's (INCY) quarterly Net Income came in at $585.6 million in Q2 2026, up 44.59% on a YoY basis from $405.0 million in Q2 2025, and up 93.06% quarter-over-quarter from $303.3 million in Q1 2026.

Analysis

Incyte (INCY) Net Income (2010 - 2026) Analysis & Trends

Incyte (INCY) has reported Net Income for 17 consecutive years, with $585.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Income rose 44.59% year-over-year to $585.6 million; the trailing twelve-month figure through Jun 2026 stood at $1.6 billion (up 85.15% YoY), and the FY2025 full-year result was $1.3 billion, up 3844.96% from the prior year.
  • Net Income grew to $585.6 million in Q2 2026 per INCY's latest filing, from $303.3 million in the prior quarter.
  • Across five years, Net Income topped out at $585.6 million in Q2 2026 and bottomed at -$444.6 million in Q2 2024.
  • Historically, Net Income has averaged $174.8 million across 5 years, with a median of $170.4 million in 2023.
  • The widest YoY moves for Net Income: up 681.22% in 2024, down 318.43% in 2024.
  • Over 5 years, Net Income stood at $28.5 million in 2022, then soared by 606.51% to $201.1 million in 2023, then increased by 0.07% to $201.2 million in 2024, then jumped by 48.74% to $299.3 million in 2025, then soared by 95.67% to $585.6 million in 2026.
  • According to Business Quant data, Net Income over the past three periods registered $585.6 million, $303.3 million, and $299.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 5.53 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 3.62 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn 5.28 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -238.00 Mn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn 2.16 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn - -644.37 Mn
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn 237.01 Mn
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 585.61 Mn
10 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn 333.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 585.61 Mn
Mar 31, 2026 303.33 Mn
Dec 31, 2025 299.28 Mn
Sep 30, 2025 424.17 Mn
Jun 30, 2025 405.00 Mn
Mar 31, 2025 158.20 Mn
Dec 31, 2024 201.21 Mn
Sep 30, 2024 106.46 Mn
Jun 30, 2024 -444.60 Mn
Mar 31, 2024 169.55 Mn
Dec 31, 2023 201.08 Mn
Sep 30, 2023 171.27 Mn
Jun 30, 2023 203.55 Mn
Mar 31, 2023 21.70 Mn
Dec 31, 2022 28.46 Mn
Sep 30, 2022 112.78 Mn
Jun 30, 2022 161.43 Mn
Mar 31, 2022 37.99 Mn
Dec 31, 2021 563.86 Mn
Sep 30, 2021 181.74 Mn